Commissioner of health directed to study and report on activities to support innovations in cell and gene therapy to treat rare diseases, report required, and money appropriated.
Sponsored By: Liz Reyer (Democratic)
Failed
Personalized for You
How does this bill affect your finances?
Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Bill Overview
No Economic Impacts Identified for this Bill
Sponsors & Cosponsors
Sponsor
Liz Reyer
Democratic • House
Cosponsors
Jeff Backer
Republican • House
Kaela Berg
Democratic • House
Robert Bierman
Democratic • House
Mike Freiberg
Democratic • House
Athena Hollins
Democratic • House
Anquam Mahamoud
Democratic • House
Danny Nadeau
Republican • House
Paul Torkelson
Republican • House
Bianca Virnig
Democratic • House
Roll Call Votes
No roll call votes available for this bill.
Actions Timeline
Author added Torkelson
4/20/2026HouseIntroduction and first reading, referred to Health Finance and Policy
3/9/2026House
Bill Text
As Introduced
Related Bills
SF 4476, Omnibus Human Services supplemental appropriations
HF 3489, Licensing boards reporting required, criminal offense of grooming established, criminal penalties provided, and money appropriated.
HF 4188, Commerce policy bill.
HF 4252, Higher education finance and policy bill.
SF 2077, Omnibus Outdoor Heritage Fund, Legacy and Lands bill
SF 334, Human Services Systems Modernization Advisory Council and Legislative Commission on Human Services Systems; creation